Document is current
Any future updates will be listed below
-
Authors
Parsons, Joshua B.
Mourad, Ahmad https://orcid.org/0000-0002-3149-597X
Conlon, Brian P. https://orcid.org/0000-0002-2155-8375
Kielian, Tammy https://orcid.org/0000-0001-7624-670X
Fowler, Vance G. Jr https://orcid.org/0000-0002-8048-0897
- License Information
-
More Information
Article History
Accepted: 25 July 2025
First Online: 20 August 2025
Competing interests
: In the past 2 years, V.G.F. reports receiving the research grants to his institution from the following sponsors: NIH, Merck, Contrafect, Karius, Basilea, Janssen, Astra Zeneca and EDE; receiving compensation as a Consultant from the following companies: Akagera, Astra Zeneca, Armata, Basilea, Debiopharm, GSK, Integrated Biotherapeutics; owning stock options in Valanbio; receiving Royalties from UpToDate; and partial ownership on patent pending sepsis diagnostic. The other authors declare no competing interests.
